Investigating tumor perfusion and metabolism using multiple hyperpolarized 13C compounds: HP001, pyruvate and urea

Magnetic Resonance Imaging

Volumn 30, Issue 3, 2012, Pages 305-311

  Von Morze, Cornelius ^a   Larson, Peder E Z ^a   Hu, Simon ^a   Yoshihara, Hikari A I ^a   Bok, Robert A ^a   Goga, Andrei ^a   Ardenkjaer Larsen, Jan Henrik ^b,c   Vigneron, Daniel B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GE HEALTHCARE   (United Kingdom)

^c TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

C13; HP001; Hyperpolarized; Perfusion; Pyruvate; Urea

Indexed keywords

BIS 1,1 (HYDROXYMETHYL) [1]CYCLOPROPANE C 13; HP 001; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; PYRUVIC ACID C 13; UNCLASSIFIED DRUG; UREA C 13;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DYNAMICS; ECHO PLANAR IMAGING; EX VIVO STUDY; HYPERPOLARIZATION; IMAGE ENHANCEMENT; IMAGE QUALITY; IN VIVO STUDY; MAGNETISM; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; RAT; STEADY STATE; THREE DIMENSIONAL IMAGING; TISSUE METABOLISM; TUMOR BLOOD FLOW;

ANIMALS; CARBON ISOTOPES; CONTRAST MEDIA; CYCLOPROPANES; DISEASE MODELS, ANIMAL; IMAGING, THREE-DIMENSIONAL; LIVER NEOPLASMS, EXPERIMENTAL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MICE, TRANSGENIC; NEOPLASMS, EXPERIMENTAL; PROSTATIC NEOPLASMS; PYRUVIC ACID; RATS; RATS, SPRAGUE-DAWLEY; UREA;

MURINAE;

EID: 84857114595     PISSN: 0730725X     EISSN: 18735894     Source Type: Journal    
DOI: 10.1016/j.mri.2011.09.026     Document Type: Article

References (27)

1. Ardenkjaer-Larsen J.H., Fridlund B., Gram A., Hansson G., Hansson L., Lerche M.H., et al. Increase in signal-to-noise ratio of >10,000 times in liquid-state NMR. Proc Natl Acad Sci USA 2003, 100(18):10158-10163.
2. Golman K., Ardenkjaer-Larsen J.H., Petersson J.S., Mansson S., Leunbach I. Molecular imaging with endogenous substances. Proc Natl Acad Sci USA 2003, 100(18):10435-10439.
3. Johansson E., Månsson S., Wirestam R., Svensson J., Petersson J.S., Golman K., et al. Cerebral perfusion assessment by bolus tracking using hyperpolarized 13C. Magnetic resonance in medicine. Magn Reson Med 2004, 51(3):464-472.
4. 13C] urea in preclinical cancer models. J Magn Reson Imaging 2011, [Inpress].
5. Beks J.W., Groen A., Huizinga T., Noordhoek K.H., Smit J.M., Walter W.G. Effects of intravenously administered hypertonic urea solution. Acta Neurochir (Wien) 1965, 13(1):1-10.
6. Cunningham C.H., Chen A.P., Albers M.J., Kurhanewicz J., Hurd R.E., Yen Y.F., et al. Double spin-echo sequence for rapid spectroscopic imaging of hyperpolarized 13C. J Magn Reson 2007, 187(2):357-362.
7. 13C metabolic imaging: comparison with phase-encoded CSI. J Magn Reson 2010, 204(2):340-345.
8. Gillies R.J., Schornack P.A., Secomb T.W., Raghunand N. Causes and effects of heterogeneous perfusion in tumors. Neoplasia 1999, 1(3):197-207.
9. Chen A.P., Albers M.J., Cunningham C.H., Kohler S.J., Yen Y.F., Hurd R.E., et al. Hyperpolarized C-13 spectroscopic imaging of the TRAMP mouse at 3T-initial experience. Magn Reson Med 2007, 58(6):1099-1106.
10. 13C magnetic resonance metabolic imaging: application to brain tumors. Neuro Oncol 2010, 12(2):133-144.
11. Vaupel P., Kallinowski F., Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989, 49(23):6449-6465.
12. Wilson D.M., Keshari K.R., Larson P.E., Chen A.P., Hu S., Criekinge M.V., et al. Multi-compound polarization by DNP allows simultaneous assessment of multiple enzymatic activities in vivo. J Magn Reson 2010, 205(1):141-147.
13. Greenberg N.M., DeMayo F., Finegold M.J., Medina D., Tilley W.D., Aspinall J.O., et al. Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 1995, 92(8):3439-3443.
14. Shachaf C.M., Kopelman A.M., Arvanitis C., Karlsson A., Beer S., Mandl S., et al. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 2004, 431(7012):1112-1117.
15. 13C MR angiography using trueFISP. Magn Reson Med 2003, 50(2):256-262.
16. Hu S., Lustig M., Balakrishnan A., Larson P.E., Bok R., Kurhanewicz J., et al. 3D compressed sensing for highly accelerated hyperpolarized (13)C MRSI with in vivo applications to transgenic mouse models of cancer. Magn Reson Med 2010, 63(2):312-321.
17. Ostergaard L., Weisskoff R.M., Chesler D.A., Gyldensted C., Rosen B.R. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: mathematical approach and statistical analysis. Magn Reson Med 1996, 36(5):715-725.
18. Barrett T., Brechbiel M., Bernardo M., Choyke P.L. MRI of tumor angiogenesis. J Magn Reson Imaging: JMRI 2007, 26(2):235-249.
19. Aronen H.J., Pardo F.S., Kennedy D.N., Belliveau J.W., Packard S.D., Hsu D.W., et al. High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas. Clin Cancer Res 2000, 6(6):2189-2200.
20. Fukuda K., Taniguchi H., Koh T., Kunishima S., Yamagishi H. Relationships between oxygen and glucose metabolism in human liver tumours: positron emission tomography using (15)O and (18)F-deoxyglucose. Nucl Med Commun 2004, 25(6):577-583.
21. Hirasawa S., Tsushima Y., Takei H., Hirasawa H., Taketomi-Takahashi A., Takano A., et al. Inverse correlation between tumor perfusion and glucose uptake in human head and neck tumors. Acad Radiol 2007, 14(3):312-318.
22. Komar G., Kauhanen S., Liukko K., Seppanen M., Kajander S., Ovaska J., et al. Decreased blood flow with increased metabolic activity: a novel sign of pancreatic tumor aggressiveness. Clin Cancer Res 2009, 15(17):5511-5517.
23. Mankoff D.A., Dunnwald L.K., Gralow J.R., Ellis G.K., Charlop A., Lawton T.J., et al. Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy. J Nucl Med 2002, 43(4):500-509.
24. Miles K.A., Griffiths M.R., Keith C.J. Blood flow-metabolic relationships are dependent on tumour size in non-small cell lung cancer: a study using quantitative contrast-enhanced computer tomography and positron emission tomography. Eur J Nucl Med Mol Imaging 2006, 33(1):22-28.
25. Semple S.I., Gilbert F.J., Redpath T.W., Staff R.T., Ahearn T.S., Welch A.E., et al. The relationship between vascular and metabolic characteristics of primary breast tumours. Eur Radiol 2004, 14(11):2038-2045.
26. Stewart E.E., Chen X., Hadway J., Lee T.Y. Correlation between hepatic tumor blood flow and glucose utilization in a rabbit liver tumor model. Radiology 2006, 239(3):740-750.
27. Tateishi U., Nishihara H., Tsukamoto E., Morikawa T., Tamaki N., Miyasaka K. Lung tumors evaluated with FDG-PET and dynamic CT: the relationship between vascular density and glucose metabolism. JComput Assist Tomogr 2002, 26(2):185-190.